Local Paclitaxel Delivery for SFA Disease
NCT00821028
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Atherosclerosis
Angioplasty
Peripheral Arterial Disease
Interventions
DRUG:
Paclitaxel
Sponsor
University of Oklahoma